The “Big Five” Canadian banks offer investment funds and include Royal Bank of Canada, Toronto Dominion Bank (TD Canada Trust), Bank of Nova Scotia, Bank of Montreal and Canadian Imperial Bank of Commerce (CIBC). Let’s explore the best place for you to invest.
Latest News
House prices got you down? Consider the latest trend: buy with a friend + MORE Apr 27th
Experts say an increasing number of first-time homebuyers are contemplating buying real estate with platonic friends, not life partners, as sky-high prices in markets such as Toronto and Vancouver have eroded affordability..... More »
Shares in two major cannabis companies halted on TSX + MORE May 3rd
Shares in two of Canada's three largest cannabis companies were halted on the Toronto Stock Exchange on Thursday..... More »
Social media influencers Andrew and Tristan Tate arrested in Miami, US Marshals Service tells AP Jul 18th
Influencer brothers Andrew and Tristan Tate, whose social media empire promoting wealth, male dominance and misogyny has made them among the world’s most polarizing internet personalities, were arrested Saturday in Miami as British authorities sought their extradition on rape and….... More »
At the open: TSX falls as sliding oil prices drag energy shares + MORE May 31st
Canada’s main stock index turned negative shortly after the open on Wednesday, as a sharp decline in energy companies, hurt by falling oil prices, offset a broad rally in most other sectors.
.... More »
Why did Pfizer, Moderna COVID-19 vaccines get new names after approval? Experts explain - Global News Sep 19th
Why did Pfizer, Moderna COVID-19 vaccines get new names after approval? Experts explain Global NewsBig gap between Pfizer, Moderna vaccines seen for preventing COVID hospitalizations Yahoo News CanadaCovid-19 breakthrough infections: 4 reasons some people get them In.... More »
Suncor, Total deal points to declining values for oil sands assets
– theglobeandmail.com
Analysts mixed on whether the Canadian firm landed a good buy, or made a questionable move considering crude prices could remain subdued for years
Number of women on Alberta corporate boards lower than national average: report
– canadianbusiness.com
EDMONTON – A report suggests the number of women who sit on corporate boards in Alberta is less than half the national average, although their presence is slowly increasing.
The study commissioned by the Alberta Securities Commission was done by the University of Calgary’s Haskayne School of Business.
It says women make up 6.6 per cent of corporate board members in the province and 8.9 per cent for companies in Alberta listed on the Toronto Stock Exchange.
An Alberta government website says women’s representation on corporate boards in Canada is 14.5 per cent. Catalyst, a non-profit group, estimates women’s share of board seats on Canadian stock index companies at 21 per cent.
Loren Falkenberg, associate dean of research, said the report aims to shed light on Alberta boardrooms in the hope the data will get corporate leaders to think differently about who they hire.
“I think there is room for more women to serve on boards,” she said Tuesday.
The data reflects the large number of energy, mining and other resource industries in Alberta…
The study commissioned by the Alberta Securities Commission was done by the University of Calgary’s Haskayne School of Business.
It says women make up 6.6 per cent of corporate board members in the province and 8.9 per cent for companies in Alberta listed on the Toronto Stock Exchange.
An Alberta government website says women’s representation on corporate boards in Canada is 14.5 per cent. Catalyst, a non-profit group, estimates women’s share of board seats on Canadian stock index companies at 21 per cent.
Loren Falkenberg, associate dean of research, said the report aims to shed light on Alberta boardrooms in the hope the data will get corporate leaders to think differently about who they hire.
“I think there is room for more women to serve on boards,” she said Tuesday.
The data reflects the large number of energy, mining and other resource industries in Alberta…
Markets took a hit on Tuesday from falling commodities prices and the widening scandal around Volkswagen’s emissions fiddle.
The Financial Post’s Jonathan Ratner looks at some of the day’s top business and financial stories.
Turing Pharmaceuticals says will cut price of drug after accused of gouging patients
– canadianbusiness.com
SAN FRANCISCO – The company that sparked an angry backlash after it raised the price of a drug for treating a deadly parasitic infection by more than 5,000 per cent says it will roll back some of the increase.
Turing Pharmaceuticals CEO Martin Shkreli told ABC News on Tuesday that the new price would make Daraprim more accessible, although he did not say what the new price for the drug would be. A spokesman for Turing did not immediately respond to a request for details.
“We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” Shkreli told ABC.
The company obtained rights to sell the drug, the only U.S.-approved treatment for toxoplasmosis, in August. It hiked the price overnight from $13.50 per pill to $750.
Turing had said it would use profits to improve the drug’s formulation and develop new, better drugs for the infection. It also stressed that some patients can get financial aid from the company to obtain the drug…
Turing Pharmaceuticals CEO Martin Shkreli told ABC News on Tuesday that the new price would make Daraprim more accessible, although he did not say what the new price for the drug would be. A spokesman for Turing did not immediately respond to a request for details.
“We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” Shkreli told ABC.
The company obtained rights to sell the drug, the only U.S.-approved treatment for toxoplasmosis, in August. It hiked the price overnight from $13.50 per pill to $750.
Turing had said it would use profits to improve the drug’s formulation and develop new, better drugs for the infection. It also stressed that some patients can get financial aid from the company to obtain the drug…
